a2 Milk (ASX:A2M) Shares Hit Two-Year High After Guidance Upgrade, Dividend Increase
By Jack |ACB News
The a2 Milk Company Ltd (ASX: A2M) rose to a two-year high after the dairy and infant formula group reported strong first-half results, upgraded its FY26 outlook and lifted its interim dividend.
In early Wednesday trade, shares touched A$9.92, their highest level since the stock rebounded from around A$3.70 in 2024, following the release of the company’s results for the six months ended 31 December 2025.
On a continuing operations basis — excluding the divested Mataura Valley Milk business — a2 Milk reported revenue of NZ$993.5 million, up 18.8% year-on-year. Earnings before interest, tax, depreciation and amortisation (EBITDA) rose 18.4% to NZ$155.0 million, while net profit after tax (NPAT) increased 9.4% to NZ$112.1 million. Basic earnings per share rose 9.2% to 15.5 New Zealand cents.
Excluding losses and one-off transformation costs linked to the ramp-up of its a2 Pokeno manufacturing facility, underlying EBITDA climbed 25.9% to NZ$164.8 million, and underlying NPAT rose 19.6% to NZ$122.6 million.
Revenue growth was broad-based, with China and Other Asia up 20.3%, Australia and New Zealand up 8.8%, and the United States up 29.1%. The company said it remained a top-four brand in China’s infant milk formula market with an estimated market share of 8.2%, up 0.2 percentage points from FY25.
Gross margin declined to 48.9%, down 1.1 percentage points, which the company attributed mainly to temporary manufacturing losses at its underutilised Pokeno facility.
The board declared an interim dividend of 11.5 New Zealand cents per share, representing a payout ratio of about 74% of continuing operations NPAT. The company reiterated its intention to declare a NZ$300 million special dividend, subject to regulatory approvals.
a2 Milk upgraded FY26 guidance and now expects mid double-digit revenue growth, an EBITDA margin of 15.5% to 16.0%, and NPAT to be higher than FY25.
Copyright Notice
All articles labeled as “Original” on ACB News (澳华财经在线) are protected by copyright.
Any reproduction, republication, redistribution, or adaptation of such content, in whole or in part, in Australia or elsewhere, without prior written authorization from ACB News, is strictly prohibited and constitutes copyright infringement.
相关阅读

-
【年报观察】中国市场遭遇重创 早阶婴配粉用户显著流失 The a2 Milk Company(ASX:A2M)新财年开局料将疲软 市场保持谨慎观望

-
【7.8】今日财经时讯及重要市场资讯

-
【异动股】明星奶粉股a2 Milk(ASX:A2M)中国婴配粉业务承压 供应链扰动致用户分流 FY26业绩达标难掩增长焦虑

-
【6.23】今日财经时讯及重要市场资讯

-
【异动股】The a2 Milk(ASX:A2M)Pokeno婴配粉中国标签注册获准归入a2™品牌 监管落地触发3亿澳元特别股息 股价过山车后A2M后续行情演绎引发市场高度聚焦

-
A2 Milk(ASX: A2M)因检测出蜡样芽孢杆菌毒素召回美国产品 股价盘中一度跌近两成

-
【5.4】今日财经时讯及重要市场资讯

-
【4.14】今日财经时讯及重要市场资讯
免责声明:本网站信息仅供一般参考,不构成投资或财务建议。虽力求准确与完整,但不保证信息的准确性、完整性或时效性。投资有风险,决策前请咨询专业独立顾问。使用本网站即视为接受本免责声明。
热门点击
-
- 中国平安保险拟退出悉尼CBD地标Salesforce Tower持股 交易对价或达9亿澳元
-
- Westpac(ASX:WBC)房贷申请量骤减引发银行股震动 房贷超级周期终结疑虑扰动市场情绪
-
- 【8.17】今日财经时讯及重要市场资讯
-
- 【8.18】今日财经时讯及重要市场资讯
-
- 5.4万亿美元资本需求背后矿业交付面临挑战 IMARC 2026悉尼国际矿业与资源大会暨展览会聚焦关键矿产供应链、融资与项目落地
-
- 澳股新周伊始面临多重压力 BHP、CSL、NAB财报前夕市场步入关键考验期
-
- 做空者围猎澳洲“明星股”:当散户狂热退潮 估值神话遭遇清算?
-
- 【年报观察】中国市场遭遇重创 早阶婴配粉用户显著流失 The a2 Milk Company(ASX:A2M)新财年开局料将疲软 市场保持谨慎观望
-
- 【8.19】今日财经时讯及重要市场资讯
-
- AUSTRAC“Operation Claw”揭开房贷欺诈黑幕 全澳可疑贷款膨胀至40亿澳元 数百经纪人、律师、会计师及高风险公司线索遭跨部门排查
-
- 【8.20】今日财经时讯及重要市场资讯
-
- 更多澳人资产达百万美元 澳人财富中位数位列全球第三
-
- 【8.21】今日财经时讯及重要市场资讯
-
- 【异动股】和邦生物确认参与募资 磷酸盐矿企Avenira (ASX:AEV) 发起4900万澳元供股发行
-
- 【7.10】今日财经时讯及重要市场资讯

